{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:33:29Z","timestamp":1790645609635,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.amjms.2022.05.019","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T02:36:03Z","timestamp":1653100563000},"page":"661-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The hypereosinophilic syndrome - an unusual cause of myocarditis and cardioembolic strokes"],"prefix":"10.1016","volume":"364","author":[{"given":"Dylan","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovais","family":"Inamullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"El Husseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Angelica","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuwei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjms.2022.05.019_bib0001","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajh.26352","article-title":"World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Shomali","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjms.2022.05.019_bib0002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1750-1172-2-37","article-title":"Hypereosinophilic syndromes","volume":"2","author":"Roufosse","year":"2007","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.amjms.2022.05.019_bib0003","doi-asserted-by":"crossref","first-page":"607-612 e9","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.amjms.2022.05.019_bib0004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jacc.2019.11.024","article-title":"Embolic stroke of undetermined source: JACC review topic of the week","volume":"75","author":"Ntaios","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.amjms.2022.05.019_bib0005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.iac.2007.07.004","article-title":"Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders","volume":"27","author":"Ackerman","year":"2007","journal-title":"Immunol Allergy Clin N Am"},{"issue":"2","key":"10.1016\/j.amjms.2022.05.019_bib0006","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12016-015-8506-7","article-title":"Hypereosinophilic syndrome","volume":"50","author":"Curtis","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.amjms.2022.05.019_bib0007","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.iac.2007.06.001","article-title":"Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome","volume":"27","author":"Bain","year":"2007","journal-title":"Immunol Allergy Clin N Am"},{"issue":"15","key":"10.1016\/j.amjms.2022.05.019_bib0008","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199910073411503","article-title":"Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia","volume":"341","author":"Simon","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjms.2022.05.019_bib0009","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2006.02.042","article-title":"Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report","volume":"117","author":"Klion","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.amjms.2022.05.019_bib0010","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ajh.25945","article-title":"Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: data from 151 patients","volume":"95","author":"Rohmer","year":"2020","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.amjms.2022.05.019_bib0011","doi-asserted-by":"crossref","first-page":"1319-25 e3","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjms.2022.05.019_bib0012","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cancergen.2017.05.001","article-title":"A novel TRIP11-FLT3 fusion in a patient with a myeloid\/lymphoid neoplasm with eosinophilia","volume":"216-217","author":"Chung","year":"2017","journal-title":"Cancer Genet"},{"issue":"3","key":"10.1016\/j.amjms.2022.05.019_bib0013","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.iac.2007.07.002","article-title":"Lymphocytic variant hypereosinophilic syndromes","volume":"27","author":"Roufosse","year":"2007","journal-title":"Immunol Allergy Clin N Am"},{"issue":"17","key":"10.1016\/j.amjms.2022.05.019_bib0014","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MD.0000000000000088","article-title":"The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype","volume":"93","author":"Lefevre","year":"2014","journal-title":"Medicine. (Baltimore)"},{"issue":"6","key":"10.1016\/j.amjms.2022.05.019_bib0015","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.jaip.2021.01.030","article-title":"CD3(-)CD4(+) lymphocytic variant hypereosinophilic syndrome: diagnostic tools revisited","volume":"9","author":"Carpentier","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.amjms.2022.05.019_bib0016","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/ejh.12842","article-title":"IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: a comparative case series","volume":"98","author":"Carruthers","year":"2017","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.amjms.2022.05.019_bib0017","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/ejh.13437","article-title":"Causes of hypereosinophilia in 100 consecutive patients","volume":"105","author":"Moller","year":"2020","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.amjms.2022.05.019_bib0018","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-97-1-78","article-title":"NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations","volume":"97","author":"Fauci","year":"1982","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.amjms.2022.05.019_bib0019","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7326\/0003-4819-102-1-109","article-title":"Neurologic dysfunction in the idiopathic hypereosinophilic syndrome","volume":"102","author":"Moore","year":"1985","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.amjms.2022.05.019_bib0020","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","article-title":"The idiopathic hypereosinophilic syndrome","volume":"83","author":"Weller","year":"1994","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.amjms.2022.05.019_bib0021","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.amjms.2017.04.002","article-title":"Eosinophilic myocarditis","volume":"354","author":"Cheung","year":"2017","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.amjms.2022.05.019_bib0022","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/archneurol.2009.36","article-title":"Cerebral arteriolar thromboembolism in idiopathic hypereosinophilic syndrome","volume":"66","author":"Grigoryan","year":"2009","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.amjms.2022.05.019_bib0023","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.iac.2007.07.001","article-title":"Cardiovascular manifestations of hypereosinophilic syndromes","volume":"27","author":"Ogbogu","year":"2007","journal-title":"Immunol Allergy Clin N Am"},{"issue":"1-2","key":"10.1016\/j.amjms.2022.05.019_bib0024","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jns.2012.12.002","article-title":"Embolism and impaired washout: a possible explanation of border zone strokes in hypereosinophilic syndrome","volume":"325","author":"Aida","year":"2013","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.amjms.2022.05.019_bib0025","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1212\/WNL.41.6.855","article-title":"Cardiac sources of embolism and cerebral infarction\u2013clinical consequences and vascular concomitants: the Lausanne stroke registry","volume":"41","author":"Bogousslavsky","year":"1991","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.amjms.2022.05.019_bib0026","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.410260612","article-title":"Computed tomographic patterns of proven embolic brain infarctions","volume":"26","author":"Ringelstein","year":"1989","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.amjms.2022.05.019_bib0027","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/01.STR.22.9.1117","article-title":"Clinical and hemodynamic aspects of low-flow infarcts","volume":"22","author":"Weiller","year":"1991","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.amjms.2022.05.019_bib0028","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/01.wnl.0000277656.36206.ca","article-title":"Watershed infarction due to acute hypereosinophilia","volume":"70","author":"McMillan","year":"2008","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.amjms.2022.05.019_bib0029","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archneur.55.11.1475","article-title":"Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke","volume":"55","author":"Caplan","year":"1998","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.amjms.2022.05.019_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000090791","article-title":"Is hypoperfusion an important cause of strokes? If so, how?","volume":"21","author":"Caplan","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.amjms.2022.05.019_bib0031","first-page":"135","article-title":"The hypereosinophilic syndrome: dramatic response to therapeutic intervention","volume":"90","author":"Parrillo","year":"1977","journal-title":"Trans Assoc Am Phys"},{"issue":"3","key":"10.1016\/j.amjms.2022.05.019_bib0032","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1586\/ehm.12.14","article-title":"Clinical management of the hypereosinophilic syndromes","volume":"5","author":"Cogan","year":"2012","journal-title":"Expert Rev Hematol"},{"issue":"9","key":"10.1016\/j.amjms.2022.05.019_bib0033","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00277-017-3067-x","article-title":"Imatinib in myeloid\/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase","volume":"96","author":"Jawhar","year":"2017","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.amjms.2022.05.019_bib0034","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jaci.2020.08.037","article-title":"Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a phase III, randomized, placebo-controlled trial","volume":"146","author":"Roufosse","year":"2020","journal-title":"J Allergy Clin Immunol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922002415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922002415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:41:43Z","timestamp":1757702503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962922002415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0002962922002415"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2022.05.019","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The hypereosinophilic syndrome - an unusual cause of myocarditis and cardioembolic strokes","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2022.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}